Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Sylvamo
SLVM
$1.49B
| $383K | ﹤0.01% |
+7,879
| New | +$378K |
|
|
CYBR
1852
DELISTED
CyberArk
CYBR
| $383K | ﹤0.01% |
2,951
| – | – |
|
|
VMGA
1853
DELISTED
VMG Consumer Acquisition Corp. Class A Common Stock
VMGA
| $382K | ﹤0.01% |
37,645
-37,355
| -50% | -$376K |
|
1854
Green Plains
GPRE
$1.18B
| $382K | ﹤0.01% |
12,545
+3,701
| +42% | +$114K |
|
1855
Reynolds Consumer Products
REYN
$5.26B
| $382K | ﹤0.01% |
12,730
-12,730
| -50% | -$382K |
|
1856
Supernus Pharmaceuticals
SUPN
$2.59B
| $381K | ﹤0.01% |
10,695
-10,695
| -50% | -$372K |
|
1857
Sabre
SABR
$731M
| $379K | ﹤0.01% |
61,377
-61,381
| -50% | -$343K |
|
|
CSGS
1858
DELISTED
CSG Systems International
CSGS
| $379K | ﹤0.01% |
6,624
| – | – |
|
1859
ICF International
ICFI
$1.46B
| $379K | ﹤0.01% |
3,827
+1
| +0% | +$109 |
|
1860
Integer Holdings
ITGR
$4.12B
| $376K | ﹤0.01% |
5,494
| – | – |
|
1861
Lakeland Financial Corp
LKFN
$1.56B
| $374K | ﹤0.01% |
5,132
| – | – |
|
1862
Roivant Sciences
ROIV
$24.5B
| $373K | ﹤0.01% |
46,664
-46,664
| -50% | -$260K |
|
|
CPRX
1863
DELISTED
Catalyst Pharmaceutical
CPRX
| $372K | ﹤0.01% |
20,016
-20,018
| -50% | -$308K |
|
1864
CBIZ
CBZ
$2.99B
| $370K | ﹤0.01% |
7,899
+1
| +0% | +$48 |
|
1865
Applovin
APP
$133B
| $370K | ﹤0.01% |
+35,137
| New | +$515K |
|
1866
Victory Capital Holdings
VCTR
$6.19B
| $369K | ﹤0.01% |
13,743
-17,621
| -56% | -$495K |
|
1867
Strategic Education
STRA
$1.85B
| $369K | ﹤0.01% |
4,708
+1
| +0% | +$74 |
|
|
CNR
1868
Core Natural Resources Inc
CNR
$4.02B
| $368K | ﹤0.01% |
5,667
+1
| +0% | +$67 |
|
1869
Delek US
DK
$4.16B
| $368K | ﹤0.01% |
13,607
-13,607
| -50% | -$402K |
|
1870
Ingevity
NGVT
$2.54B
| $367K | ﹤0.01% |
5,208
| – | – |
|
|
EDR
1871
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $366K | ﹤0.01% |
16,213
-16,217
| -50% | -$346K |
|
|
KNBE
1872
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $362K | ﹤0.01% |
14,619
-14,619
| -50% | -$356K |
|
|
JWN
1873
DELISTED
Nordstrom
JWN
| $362K | ﹤0.01% |
22,437
-22,439
| -50% | -$430K |
|
1874
CareTrust REIT
CTRE
$9.91B
| $362K | ﹤0.01% |
19,479
-19,481
| -50% | -$364K |
|
1875
Bread Financial
BFH
$4.37B
| $362K | ﹤0.01% |
9,598
+1
| +0% | +$36 |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.